Security key
03843E104
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)
CUSIP: 03843E104
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.001 par value
- Total 13F shares
- 72,216,999
- Total 13F value
- $466,378,990
- Share change
- +4,963,541
- Put/Call ratio
- 139%
- SEC-reported price per share
- $6.46
- Number of holders
- 178
- Value change
- +$34,098,128
- Number of buys
- 112
- Number of sells
- 60
- Shares outstanding
- 120,192,308
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2025
Institutions
178
Top holders
10
AQST full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Aquestive Therapeutics, Inc. SEC filings
Aquestive Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03843E104
Recent filing periods:
Ownership snapshot
Top reported holders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Douglas K. Bratton
Disclosed value leader
Bratton Capital Managemen...
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
3/4/5
13F
Lead comparable stake: 11%
13D/G row: Douglas K. Bratton
Showing 1-6 of 15 holder rows.
Quick read
Douglas K. Bratton leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Douglas K. Bratton
11%
BlackRock, Inc.
5.3%
RTW INVESTMENTS, LP
5.2%
Venrock Healthcare Capital Partne...
2.9%
Bratton Capital Management, L.P.
8.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Douglas K. Bratton |
13D/G
3/4/5
BRATTON DOUGLAS K · 10%+ Owner
|
11%
|
$28,720,687
10,077,434 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.3%
from 13D/G
|
$36,478,567
6,525,683 shares
|
— | 30 Sep 2025 |
| RTW INVESTMENTS, LP |
13D/G
13F
Company
|
5.2%
|
$34,937,500
6,250,000 shares
|
$0 | 30 Sep 2025 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
2.9%
|
$7,494,890
2,629,786 shares
|
$0 | 31 Dec 2024 |
| Bratton Capital Management, L.P. |
13F
Company
|
8.2%
|
$54,843,255
9,810,958 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
4.7%
|
$31,651,318
5,662,132 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
178
Shares
72,216,999
Rows available
178
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
151
Q4 2025 holders
178
Holder diff
27
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend